Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 32 | 27 | −5 |
| Shares | 9.95M | 9.96M | +11.3K (+0.1%) |
| Value | $18.8M | $2.90M | −$15.9M (−84.6%) |
New holders (4)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 49,165 | $14.0K | 0.00% |
| Virtu Financial LLC | 28,362 | $8.00K | 0.00% |
| FMR LLC | 14 | $4 | 0.00% |
| Royal Bank of Canada | 271 | $0 | 0.00% |
Sold out (9)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 41,874 | $79.1K |
| Citadel Advisors LLC | 19,986 | $37.8K |
| X-Square Capital, LLC | 17,743 | $34.0K |
| Jane Street Group, LLC | 16,982 | $32.1K |
| Two Sigma Advisers, LP | 10,300 | $19.5K |
| UBS Group AG | 6,017 | $11.4K |
| Advisory Services Network, LLC | 2,000 | $3.78K |
| TCI Wealth Advisors, Inc. | 100 | $189 |
| Simplex Trading, LLC | 447 | $0 |